In recent trading session, Applied Dna Sciences Inc (NASDAQ:APDN) saw 3.42 million shares changing hands at last check today with its beta currently measuring 0.31. Company’s recent per share price level of $1.68 trading at $0.08 or 5.00% at last check today assigns it a market valuation of $1.86M. That most recent trading price of APDN’s stock is at a discount of -26685.71% from its 52-week high price of $450.00 and is indicating a premium of 13.69% from its 52-week low price of $1.45. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.86 million shares which gives us an average trading volume of 895.84K if we extend that period to 3-months.
For Applied Dna Sciences Inc (APDN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -3.0 in the current quarter.
Applied Dna Sciences Inc (NASDAQ:APDN) trade information
Upright in the green today for gaining 5.00%, in the last five days APDN remained trading in the red while hitting it’s week-highest on Tuesday, 04/01/25 when the stock touched $1.68 price level, adding 18.64% to its value on the day. Applied Dna Sciences Inc’s shares saw a change of -83.53% in year-to-date performance and have moved -10.16% in past 5-day. Applied Dna Sciences Inc (NASDAQ:APDN) showed a performance of -73.81% in past 30-days. Number of shares sold short was 0.23 million shares which calculate 2.06 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 1.5 to the stock, which implies a fall of -12.0% to its recent value today. Analysts have been projecting 1.5 as a low price target for the stock while placing it at a high target of 1.5. It follows that stock’s current price would jump 10.71% in reaching the projected high whereas dropping to the targeted low would mean a gain of 10.71% for stock’s current value.
Applied Dna Sciences Inc (APDN) estimates and forecasts
This year revenue growth is estimated to rise 53.99% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.19M for the same. And 1 analysts are in estimates of company making revenue of 1.28M in the next quarter. Company posted 929.63k and 797.52k of sales in current and next quarters respectively a year earlier. Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 60.68% during past 5 years.
Applied Dna Sciences Inc (NASDAQ:APDN)’s Major holders
Insiders are in possession of 19.47% of company’s total shares while institution are holding 26.89 percent of that, with stock having share float percentage of 33.39%. Investors also watch the number of corporate investors in a company very closely, which is 26.89% institutions for Applied Dna Sciences Inc that are currently holding shares of the company. MATHER GROUP, LLC. is the top institutional holder at APDN for having 700.0 shares of worth $287.0. And as of 2024-06-30, it was holding 0.0803 of the company’s outstanding shares.
On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jan 31, 2025, the former fund manager was holding 5.65 shares of worth $9440.0 or 0.01% of the total outstanding shares. The later fund manager was in possession of 174.0 shares on Dec 31, 2024, making its stake of worth around $290.0 in the company or a holder of 0.00% of company’s stock.
